Deal value increased by 320 per cent in September 2025, compared to September 2024 EP News Bureau Oct 10, 2025 Three major deals contributed 79.7 per cent of the total deal value during September 2025
M&A in pharma sees deals worth $14.8 bn in Nov 2024 EP News Bureau Dec 9, 2024 According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
Double digit MCap growth in 2019 for 14 of top 20 pharma companies: GlobalData EP News Bureau Jun 18, 2020 Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100 per cent YoY growth in…
